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Objectives: Peripheral blood parameters implicating the irreversible damages of cardiogenic shock under extra-
corporeal membrane oxygenation (ECMO) support patients were investigated.
Methods: The blood was collected from 23 cardiogenic shock cases at the time of ECMO installation, and 2, 6, 12,
and 24 h after oxygenation. Plasma levels of IL-2, IL-6, IL-7, IL-8, IL-10, IFN-γ, MCP-1, and carbonic anhydrase IX
(CA IX) were determined by ELISA. Reactive oxygen species were measured by luminol and lucigenin and leuko-
cyte subpopulations were analyzed by ﬂow cytometry. Generalized additive models (GAMs) were performed to
identify the death ranges of every variable and the variableswere further discretized at each timepoint. The com-
bination of predictors was selected from both original and discretized covariates by the generalized linearmodel
(GLM) at each time point.
Results: Plasma IL-10 level was the most distinct biomarker between survivors and non-survivors after oxygen-
ation. IL-10 sequentially partnered with IL-6, IL-7, and lymphocyte percentage at 2 h, with CD3+CD4+ T cells at
6 h,with CA IX at 12 h, and CD3+ T lymphocytes at 24 h predicted deathwith AUCs 1.000, 0.975, 0.992, and 0.992,
respectively.
Conclusions: Combination of the GAM plots and GLM models overcame the complexity of different disease
categories. The systemic irreversible damages from cardiogenic shock ECMO casesmight be detected from several
peripheral blood parameters.
© 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Cardiogenic shock (CS) is typically the result of severe left ventricular
contractile failure which causes systemic anoxia, hypoxia, and ischemia.
The extreme stress has been proposed to stimulate sympathetic nerve to
release catecholamine in acute myocardial infarction (AMI) patients
with 2.5- to 3-fold elevation than the controls [1], and catecholamine
has been shown to directly stimulate the promoter/enhancer of IL-10, National Taiwan University





nd Ltd. This is an open access article unby targeting a cAMP responsive element (CRE) in monocytes, but
not in T-cells, after AMI without preceding inﬂammation [2,3]. Rapid
monocytic IL-10 release after sympathetic activation may represent
a common pathway for immunosuppression induced by stress. The
extracorporeal membrane oxygenation (ECMO) support has been used
for CS rescue. IL-10 and superoxide ions were shown to predict death/
survival of ECMO therapy for CS patients as early as at installation before
resuscitation [4]. Our hypothesis is that the effects of CS and ECMO
therapy are systemic; therefore, peripheral blood dynamic changes
might shed light of body response, particular the different response
between death and survival. Dynamic changes of reactive oxygen
species (ROS), peripheral blood leukocyte subpopulations, plasma cyto-
kines and carbonic anhydrase IX, a hypoxia marker [5,6], were investi-
gated in CS ECMO cases within 24 h after ECMO treatment and the
differences between survivors and non-survivors were also analyzed
in this study.der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Table 1
Demographic and clinical characteristics of cardiogenic extracorporeal membrane oxy-
genation (ECMO) patients.
Variable Survival Death p-Value
Sample size (n) 12 (52.2%) 11 (47.8%)
Age (years) 44.96 ± 12.95 55.68 ± 19.63 0.166
Gender N0.999
Male 9 (50.0%) 9 (50.0%)
Female 3 (60.0%) 2 (40.0%)
WBC (K/μL) 13.28 ± 6.46 11.47 ± 4.96 0.347
Diagnosis group 0.856
AMI (n = 11) 5 (45.5%) 6 (54.5%)
DCMP (n = 6) 3 (50.0%) 3 (50.0%)
Myocarditis (n = 4) 3 (75.0%) 1 (25.0%)
Others (n = 2) 1 (50.0%) 1 (50.0%)
Notes: The sample statistics presented in this table weremean ± standard deviation (SD)
for continuous variables and frequency (percentage, %) for categorical variables. The listed
p-values of statistical tests were calculated using theWilcoxon rank-sum test for continu-
ous variables and the Fisher's exact test for categorical variables.
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2.1. Study population
This studywas approved by the Research Ethics Committee (REC) of
the National Taiwan University Hospital. ECMO was indicated for pa-
tients with circulatory collapse or needing inotrope support of more
than 40 inotrope equivalents (=dopamine + dobutamine + epineph-
rine × 100 + norepinephrine × 100, μg/kg/min) [7]. The ECMO system
(Medtronic Inc.) was usually set up through the femoral veno-arterial
route [7]. Inclusion criteria included age ≥18 year and cardiogenic
shock that needed ECMO support. Exclusion criteria included pre-
existing multiple organ failure, severe brain insult before ECMO, and
the absence of signed consent for study enrollment. The blood was sep-
arately collected at ECMO installation before resuscitation and 2, 6, 12,
and 24 h after oxygenation for the study.
Patients who survived for more than 7 days after the initial insult
and ECMO treatment were deﬁned as survival, and death patients
were deﬁned as mortality or multiple organ failure incompatible with
life within 7 days after ECMO was installed. To focus on the effects of
CS rescued by ECMO, the survival time was deﬁned as more than
7 days to avoid the complications after the rescue. Irreversible damages
from CS often cause multiple organ failure; therefore, multiple organ
failure incompatible with life within 7 days after ECMO was deﬁned as
death, failure of rescue.
2.2. ROS determined by luminol and lucigenin
The blood was collected into a sodium heparin Vacutainer tube, was
kept on ice and was analyzed within 1 h. Total ROS activity was mea-
sured by 0.2 mL of blood reacting with 1 mL of 0.3 mM luminol for
4 min at 37 °C in a Chemiluminescence Analyzer (Tohoku Electronic
Industrial). The plasma superoxide ion measurement was done by
reacting 0.2 mL of blood with 1 mL of 0.1 mM lucigenin at 37 °C for
4 min.
2.3. IL-2, IL-6, IL-7, IL-8, IL-10, interferon-γ (IFN-γ), monocyte chemotactic
protein-1 (MCP-1), and CA IX
The plasma concentrations of IL-2, IL-6, IL-8, IL-10, interferon-γ
(IFN-γ), and MCP-1 were separately analyzed using commercial ELISA
kits (Becton Dickinson, BD). The IL-7 ELISA kits were from BioLegend.
Plasma CA IX levels were also measured by a commercial ELISA kit
(R&D Systems).
2.4 . Flow cytometric analysis
The blood was collected into a Vacutainer tube containing EDTA.
One hundred microliters of blood per tube was separately stained
with four or three or two-color combinations of CD19 APC/CD3 PerCP/
CD4 FITC/CD8 PE, CD3 PerCP/CD16 FITC/CD56 PE, CD14 PE/CD16 FITC
(Becton Dickinson) at room temperature for 25 min in the dark, lysed
with BD lysing solution,washed two timeswith phosphate buffer saline
(PBS) containing 1% heat-inactivated fetal bovine serum, and ﬁxedwith
PBS containing 0.25% paraformaldehyde. Cells were analyzed and
20,000 events were collected per assay by a BD Calibur ﬂow cytometer
with CellQuest software version 3.2.
2.5. Statistical analysis
R software (http://www.r-project.org/), version 2.15.2, was used for
the analysis of the generalized additivemodels (GAMs) for simple logis-
tic regression and the generalized linear model (GLM) for maximum-
likelihood estimation. Due to wide distributions of IL-2, IL-6, IL-7, IL-8,
IL-10, IFN-γ, MCP-1, CA IX, ROSdeterminedby luminol and by lucigenin,
the log values of these variables were used for GAM and GLM analysis.The GAM plot was generated after smoothing each component. The
X-axis represents the covariate, and the Y-axis is logit (probability of
death) or equivalently, the log value of the odds; Y N0 for death, Y b0
for survival. Case distributions were shown as short vertical lines
along the X-axis. The prediction power was conducted by GLM analysis.
The β is the estimated regression coefﬁcient; se is the estimated stan-
dard error of β; VIF is the variance inﬂating factor; R2 is the adjusted
generalized R2 (Nagelkerke R2); the modiﬁed Hosmer–Lemeshow
goodness-of-ﬁt test, a statistical test for goodness of ﬁt for logistic
regression model, was abbreviated as the H-L GOF test. The positive
value of β indicated that the higher the value the worse condition the
patient could be. The variance inﬂation factor (VIF) is a simple diagnos-
tic of collinearity, one for each regression coefﬁcient (other than the
intercept). Values of VIF exceeding 5 were considered evidence of col-
linearity. The p-value was further calculated by the likelihood ratio
(LR) test. The p b 0.05 was considered signiﬁcant.
3. Results
3.1. Demographic and clinical characteristics of patients
Total 23 patients, including 11 AMI, 6 dilated cardiomyopathy
(DCMP), 4 acutemyocarditis (AM), 1 arrhythmia, and 1 aortic dissection
cases, were enrolled from January 2010 to November 2011. The demo-
graphic and clinical characteristics are presented in Table 1. The detail
information was described before [4].
3.2. Death ranges were discretized for every variable according to its gener-
alized additive model plot at each time point
To overcome the complexity of AMI, DCMP, and AM disease catego-
ries, the generalized additive model (GAM) was chosen. Computing
with GAM by R was separately conducted for every variable at 0, 2, 6,
12, and 24 h; resultant death ranges were discretized accordingly. The
analysis and prediction results at 0 h were reported before [4].
3.3. Outcome prediction at 2 h: IL-10, IL-6, IL-7, and lymphocytes with AUC
1.000
Once the ECMO support was initiated, reperfusion started. The re-
sponse to I/R was systemic; whole blood ROS separately determined by
luminol and lucigenin, plasma IL-2, IL-6, IL-7, IL-8, IL-10, IFN-γ, MCP-1,
and CA IX levels determined by ELISA, lymphocytes, monocytes, and
granulocytes in percentages of white blood cells (WBC), as well as
CD19+ B, CD3+ T, CD3+CD4+ T, CD3+CD8+ T, CD16+CD56+ natural kill-
er (NK), and CD56+ NK T cells presented in both percentages of WBC
and lymphocytes by ﬂow cytometry, were separately performed and
Fig. 1. The generalized additivemodel (GAM) plots for the death model with death versus log IL-10, log IL-7, log IL-6, and lymphocyte percentages of total white blood cells (WBC) at 2-h
timepoint, respectively. TheX-axis represent the concentration log values of IL-10 in (A), IL-7 in (B), and IL-6 inC, aswell as thepercentages of lymphocytes ofWBC in (D). TheY-axis is the
logit (probability of death) or equivalently, the log value of odds; Y N 0 for death, Y b 0 for survival. The 23 short vertical lines represent 23 cases. AMI: acute myocardial infarction, DCMP:
dilated cardiomyopathy, IL: interleukin.
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composition in outcome prediction at each time point after resuscitation.
The best prediction combination was selected from all of both origi-
nal and discretized ranges with GLM by R at 2 h. The composition ofTable 2
Identifying predictors of death based on clinical and biochemical measurements at 0, 2, 6, and
Covariate β se of β
0 h (N = 23)
Log(IL-10) b 1.155, 2.808 ≤ Log(IL-10) b 3.87, or Log(IL-10) N 4.964 4.7005 1
2 h (N = 23)
Log(IL-10.2) 131.297 113515
3.765 b Log(IL7.2)Log b 5.26 135.734 115388
Log(IL-6.2) 31.164 49913
9.247% b lymphocytes_total.2 b 30.106% 77.194 76838
6 h (N = 22)
Log(IL10.6) 9.1810 7
1.437 ≤ CD3CD4_percent_total.6 b 2.562
3.286 ≤ CD3CD4_percent_total.6 b 4.525
10.4754 8
12 h (N = 22)
Log(IL-10.12) 14.501 11
Log(CA IX.12) b 6.486 16.221 12
24 h (N = 22)
Log(IL10.24) 12.9763 12
CD3_T cells_gated.24 0.2552 0
In this table, log is the natural logarithm (i.e., ln); β is the estimated regression coefﬁcient; se is
ratio test; VIF is the variance inﬂating factor; R2 is adjusted generalized R2 (Nagelkerke R2); AUC
is the modiﬁed Hosmer–Lemeshow goodness-of-ﬁt test. The symbol * is used to indicate the pIL-10, IL-6, IL-7, and lymphocytes was identiﬁed as the best prediction
group. The distribution of the diagnosis group with the case number
for every case was marked in each variable GAM plot and presented in
Fig. 1. Death cases were placed above the Y = 0 line and survival12 hour time points by logistic analysis.
Wald's test LR test VIF R2 AUC H-L GOF test Accuracy
.4802 0.001* b0.001* – 0.731 0.913 0.290 21/23
.134 0.9991 b0.0001* 2.9494 17/23
.536 0.9991 b0.0001* 4.7294 17/23
.185 0.9995 0.0011* 3.1190 15/23
.627 0.9992 0.0012* 2.2473 1.000 1.000 0.002 16/23
.1122 0.1967 0.0002* 16.8261 19/22
.0579 0.1936 0.0007* 16.8261 0.887 0.975 0.927 18/22
.143 0.1931 0.000118* 22.706
.467 0.1932 0.004473* 22.706 0.911 0.992 0.963 18/22
.8643 0.3131 b0.0001* 2.810 21/22
.3114 0.4125 0.0443* 2.810 0.939 0.992 1.000 15/22
the estimated standard error of β; OR is the estimated odds ratio; LR test is the likelihood
is the estimated area under the receiver operating characteristic (ROC) curve; H-L GOF test
values ≤ 0.05. IL: interleukin; CA IX: carbonic anhydrase IX.
Fig. 2. The generalized additivemodel (GAM)plots for the deathmodelwith death versus log IL-10, and CD3+CD4+ T lymphocyte percentages of totalwhite blood cells (WBC) at 6-h time
point, respectively. The X-axis represent the log value of IL-10 concentration in (A) and percentages of CD3+CD4+ T lymphocytes ofWBC in (B), and the Y-axis is the logit (probability of
death) or equivalently, the log value of odds; Y N 0 for death, Y b 0 for survival. The 22 short vertical lines represent 22 cases. AMI: acute myocardial infarction, DCMP: dilated cardiomy-
opathy, IL: interleukin.
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values. Short vertical lines along the X-axis represented distribution of
cases. The logistic analysis results by R are listed in Table 2. The outcome
prediction power was analyzed as the area under the receiver operating
characteristic curve (AUC) 1.000.Misplaced AMI no. 8 case in IL-10GAM
plot was correctly placed in those of IL-7 and lymphocytes. Although
cases of AMI nos. 3, 4, and 5, arrhythmia no. 1, and DCMP no. 1 were
not correctly placed in IL-10 plot, everyone was accurately placed in at
least one GAM plot of IL-6, IL-7, and lymphocytes.
3.4. Outcome prediction at 6 h: IL-10 and CD3+CD4+ T lymphocytes with
AUC 0.975
At 6 h, IL-10 and CD3+CD4+ T lymphocytes in percent of WBC
formed the best outcome prediction partners with AUC 0.975. TheGAM plots of these two variables are presented in Fig. 2 and the logistic
analysis results are listed in Table 2. Misplaced cases of AMI nos. 4 and 6
and DCMP no. 4 in IL-10 plot were correctly placed in the GAM plot of
CD3+CD4+ T lymphocytes.3.5. Outcome prediction at 12 h: IL-10 and CA IX with AUC 0.992
At 12 h, the best outcome prediction group consisted of IL-10 and CA
IX with AUC 0.992. The GAM plots of these two variables are shown in
Fig. 3 and the logistic analysis results are listed in Table 2. Plasma
IL-10 concentrations between 307.35 pg/ml and 113.07 pg/ml showed
no preference for either death or survival. Cases of DCMP nos. 1, 4, and
5 and AMnos. 1 and 2were resolved in the GAMplot of CA IX excluding
AMI no. 4 case.
Fig. 3. The generalized additive model (GAM) plots for the death model with death versus log IL-10, and log carbonic anhydrase IX (CA IX) at 12-h time point, respectively. The
X-axis represents the concentration log values of IL-10 in (A) and CA IX in (B), and the Y-axis is the logit (probability of death) or equivalently, the log value of odds; Y N 0 for death,
Y b 0 for survival. The 22 short vertical lines represent 22 cases. AMI: acute myocardial infarction, DCMP: dilated cardiomyopathy, IL: interleukin.
40 T.-H. Hong et al. / IJC Metabolic & Endocrine 7 (2015) 36–443.6. Outcome prediction at 24 h: IL-10 and CD3+ T lymphocytes with AUC
0.992
The best outcome prediction group at 24 h was composed of IL-10
and CD3+ T lymphocytes in percent of lymphocytes with AUC 0.992.
The GAM plots are presented in Fig. 4 and the logistic analysis results
are listed in Table 2. DCMP no. 5 case was not correctly placed in the
GAM plot of either IL-10 or CD3+ T lymphocytes.3.7. Dynamics of IL-10, IL-6, IL-7, CA IX, lymphocytes, CD3+CD4+ and
CD3+ T lymphocytes within 24 h after ECMO installation
Plasma IL-10 was the only variable chosen to group with different
covariates at different time points to form the best prediction part-
ners. Dynamic comparisons of IL-10, IL-6, IL-7, CA IX, lymphocytes,CD3+CD4+ and CD3+ T lymphocytes inmedian values between surviv-
al and death groups at each time point are shown in Fig. 5. The solid and
dashed lines represent death and survival groups, respectively. These
ﬁgures did not demonstrate the death ranges. The discrimination be-
tween death and survival in plasma IL-10 levels was better than any
other partners at studied time period, which explained that IL-10 was
chosen in all time points. The best distinction of death versus survival
for CA IX was at 12 h, corresponding to the best outcome prediction of
IL-10 and CA IX at this time point.
The slight rise of IL-10, IL-6, and CA IX in survival group at 2 h indi-
cated the strong response to CS and ECMO occurred in 2 h. Those survi-
vors were able to resolve and gradually returned to homeostasis status
while non-survivors were unable to resolve CS and ECMO damages,
having unbalanced inﬂammatory and anti-inﬂammatory cytokines, as
well as hypoxia condition even undergoing ECMO treatment. A steep
decrease of lymphocytes and CD3+CD4+ lymphocytes in percent of
Fig. 4. The generalized additive model (GAM) plots for the death model with death versus log IL-10, and percentages of CD3+ T lymphocytes of total lymphocytes at 24-h time point,
respectively. The X-axis represent the log value of IL-10 concentration in (A) and percentages of CD3+ T lymphocytes of total lymphocytes in (B), and the Y-axis is the logit (probability
of death) or equivalently, the log value of odds; Y N 0 for death, Y b 0 for survival. The 22 short vertical lines represent 22 cases. AMI: acute myocardial infarction, DCMP: dilated cardio-
myopathy, IL: interleukin.
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ECMO occurred not only in hearts but also in peripheral lymphocytes
and most signiﬁcant death was within 2 h after reperfusion.4. Discussion
Plasma IL-10 level was the most distinct biomarker between survi-
vors andnon-survivors after ECMO therapy. IL-10 sequentially partnered
with IL-6, IL-7, and lymphocyte percentage at 2 h, with CD3+CD4+
T cells at 6 h,with CA IX at 12 h, andCD3+T lymphocytes at 24 h predict-
ed death with high AUC values. Combined analysis by the GAM plots,
followedwith GLMmodels overcame the complexity of different disease
categories.High levels of plasma IL-6, IL-8, and IL-10 on admissionwere report-
ed to discriminate between survivors and non-survivors undergoing
successful resuscitation after cardiac arrest [8]. Our previous study indi-
cates that a proper response to cardiogenic shock by releasing the ap-
propriate amount of IL-10 is required for survival in the cases of AMI
and DCMP. For myocarditis, proper responses in IL-10 and superoxide
ions are needed [4]. Serum IL-10 levels on admission were subjected
to predict subsequent CS requiring a mechanical cardiopulmonary sup-
port system and mortality of fulminant myocarditis patients [9]. Both
wild-type and IL-10–deﬁcient mice subjected to myocardial ischemia/
reperfusion (I/R) revealed signiﬁcant levels of IL-10 present in wild-
type mice at 2 to 6 h after myocardial reperfusion whereas elevated
neutrophils in re-perfused tissues at 6 h and causing increase of infarct
size as well as myocardial necrosis in IL-10–deﬁcient mice. Endogenous
Fig. 5. Comparisons of IL-10, IL-6, IL-7, carbonic anhydrase IX (CA IX), percentages of lymphocytes and CD3+CD4+ T lymphocytes of total white blood cells, and CD3+ T lymphocytes of
total lymphocytes between survivors and non-survivors. All values of each covariate at every time point are presented with the median of the group.
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um through the suppression of neutrophil recruitment [10]. Abnormal
plasma IL-6 and IL-10 levels were most distinct in patients with the
most severe heart failure secondary to either coronary artery disease
or DCMP [11]. Plasma IL-6 reached the peak 9 h after the onset of
AMI and E-selectin reached the peak 24 h after the onset of symptom
among 24 AMI patients; therefore, cytokines and adhesion molecules
were concluded to play an important role in tissue injury in the process
of I/R [12]. Proper release of IL-10 and IL-6 shortly after I/R was neces-
sary for survival; uncontrolled release led to death. Once patients
were unable to oxygenate tissues while under ECMO treatment, plasma
CA IX levels started to increase. CA IX partnered with IL-10 was the
strongest indicator at 12 h after reperfusion.
Myocardial injury is the common stimulus acting on inﬂammatory
cell subpopulations inﬁltrated the ischemic zone,which in turn produces
inﬂammatory and anti-inﬂammatory mediators regulating the healingprocess. Additionally, the acute phase protein IL-6 is elevated during
the course of AMI, and the ratio of IL-6/IL-10 has been used as prognostic
marker of organ damage in acute inﬂammatory responses [13]. The par-
allel increase of IL-10 with IL-6 in AMI may be an adaptive mechanism
for the neutralization of action of myocardial injury inﬂammatorymedi-
ators and for the reduction of deleterious effects of pro-inﬂammatory
cytokines on human ischemic myocardium [14]. One of IL-7 expression
inducers is IL-6 [15]. IL-6 levels greatly increased from 6 h in non-
survivors while IL-7 concentrations showed increase in non-survivors
and decrease in survivors from 12 h in this study; IL-7 might have been
induced by IL-6. However, the combined prediction power of IL-10, IL-6,
IL-7, and lymphocytes was detected at 2 h. The IL-7 pathway has been
proposed to be regulated more at the level of IL-7 receptor expression
than of IL-7 [16]. Although IL-7 levels increased in non-survivors possibly
induced by IL-6, the lymphocyte percentages did not respond to IL-7. IL-7
receptor was probably unresponsive in non-survivors.
43T.-H. Hong et al. / IJC Metabolic & Endocrine 7 (2015) 36–44Cell death is a process that leads to the point of no return. Ischemic
cell death is characterized by swelling, oncosis (early phase of necrosis),
resulting from failure of ion pump [17]. Apoptosis was observed in pa-
tients ranging from 3 to 120 h after AMI [18]. Lysosomal autophagy is
activated in 30min to 3 h in CS and by 1 h and for the following 12 h co-
agulation necrosis becomes evident; and in 12×24 h post-occlusion, the
myocardial infarct is histologically completed [19]. Annexin-V labeled
apoptosis was best resolved at 22.5 h after reperfusion in AMI patients
[20]. Autophage, necrosis, and apoptosis were described in cardiomyo-
cyte death [21]. The cardiac injury from 45-minute ischemia followed
by reperfusion was reversible in isolated canine hearts; however, ne-
crotic damage from 90-minute ischemia followed by reperfusion was
not reversible. Furthermore, DNA fragmentation was not observed in
isolated canine heartswith 6 h ischemiawithout reperfusion. Therefore,
apoptotic cell deathwas concluded to be initiated by ischemia and com-
pleted by reperfusion. Cell death in acute ischemia followed by reperfu-
sion occurs predominantly by necrosis, and apoptosis is of minor
importance in this pathophysiological situation [22].
The CS ECMO patients underwent systemic I/R. A sharp percentage
decrease of lymphocytes and CD4 T cells occurred in 2 h after reperfu-
sion, which indicated that peripheral lymphocytes died within 2 h
after I/R. Although the death mechanism was not investigated in this
study, we demonstrated that it was possible to predict the outcome of
CS patients with ECMO support from peripheral blood component
analysis.
The limitation of this study was the sample size. It was very difﬁcult
to explain this study to anxious family members in order to have con-
sent forms sighed while patients were being rescued, which limited
the enrolled cases. We present the results from 23 cases of study.
5. Conclusions
The combination of the GAM plots and GLM models overcame the
complexity of different cardiovascular disease categories. The systemic
irreversible damages from CS ECMO cases might be detected from
IL-10 partnered with peripheral blood parameters in early phase after
ECMO installation.
Key messages
• The combination of the GAM plots and GLM models overcame the
complexity of different cardiovascular disease categories.
• Plasma IL-10 levelwas themost distinct biomarker between survivors
and non-survivors after reperfusion.
• The systemic irreversible damages from CS ECMO cases might be
detected from several peripheral blood parameters.
• IL-10 sequentially partnered with IL-6, IL-7, and lymphocyte percent-
age at 2 h, with CD3+CD4+ T cells at 6 h, with CA IX at 12 h, and CD3+
T lymphocytes at 24 h predicted death with high AUC values.Conﬂict of interest
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